Yaa Ababio

Pfizer (United States) — United States

Medicine · Health Sciences

2h-index66citations5works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiomyopathy and Myosin Studies(2), Cancer Immunotherapy and Biomarkers(1), Healthcare Policy and Management(1), Renal cell carcinoma treatment(1), Global Cancer Incidence and Screening(1)

Publications5 total

Real-world community oncology-based treatment patterns for first line axitinib plus pembrolizumab in advanced renal cell carcinoma: Initial dosing, dose reductions and clinical outcomes.
Journal of Clinical Oncology·2025
Prevalence and Clinical Burden of Idiopathic Dilated Cardiomyopathy in the United States
American Journal of Medicine Open·2023· 21 citedOpen Access
ISPE20 Author Index
Pharmacoepidemiology and Drug Safety·2022· 1 citedOpen Access
Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity
Healthcare·2022· 42 citedOpen Access
Prevalence and Clinical Burden of Idiopathic Dilated Cardiomyopathy in the United States
SSRN Electronic Journal·2022· 2 citedOpen Access

Frequent Co-authors

Scott P. Kelly(3), Franca S. Angeli(2), Joanne Berghout(2), Kui Huang(2), Kathy Liu(2), Sara Burns(2), Rob Moccia(2), Gabriel Brooks(2), Mark R. Cullen(1), Adina R. Lemeshow(1), Leo Russo(1), David M. Barnes(1), Aida Habtezion(1), Cynthia Senerchia(1), Cynthia Senerchia(1), Rune Aabenhus(1), Mia Aakjær(1), Robertus van Aalst(1), Asmaa Abbas(1), A.R. Abdelaziz(1)